NCT04414683

Brief Summary

To elucidate factors affecting survival of early stage ovarian cancer

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 13, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 31, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 4, 2020

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

September 15, 2023

Status Verified

September 1, 2023

Enrollment Period

4.7 years

First QC Date

May 31, 2020

Last Update Submit

September 14, 2023

Conditions

Ovarian Cancer

Outcome Measures

Primary Outcomes (1)

  • Factors affecting overall survival of early ovarian cancer

    10 years

Secondary Outcomes (1)

  • Factors affecting progression-free survival of early ovarian cancer

    10 years

Interventions

staging surgeryPROCEDURE

laparoscopic or laparotomic staging surgery

Eligibility Criteria

Age20 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailsovarian cancer
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with early stage ovarian cancer

You may qualify if:

  • early stage ovarian cancer

You may not qualify if:

  • Nil.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital

Banqiao District, New Taipei, 22050, Taiwan

RECRUITING

MeSH Terms

Conditions

Ovarian Neoplasms

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Neoplasms, FemaleUrogenital NeoplasmsGenital DiseasesEndocrine System DiseasesGonadal Disorders

Central Study Contacts

Sheng-Mou Hsiao, MD

CONTACT

+886919302632smhsiao2@gmail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief of Department of Obstetrics & Gynecology

Study Record Dates

First Submitted

May 31, 2020

First Posted

June 4, 2020

Study Start

April 13, 2020

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

September 15, 2023

Record last verified: 2023-09

Locations

TW(1)